[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
RegulatoryConnect The MHRA’s new ‘Front Door’

RegulatoryConnect The MHRA’s new ‘Front Door’

by Steven Hewison | Mar 13, 2024 | Blog, MHRA

The MHRA have made the first release of their RegulatoryConnect service available which allows tracking of the submission status of product licence applications but will soon offer much more.

Wholesale Dealing in Veterinary Medicines

Wholesale Dealing in Veterinary Medicines

by Steven Hewison | Dec 12, 2023 | Blog, Veterinary Medicines, WDA(V)

In order to legally run a business that deals with the wholesale of animal medicines (veterinary medicinal products) you must obtain a veterinary medicines Wholesale Distribution Authorisation (WDA(V)) from the Veterinary Medicines Directorate (VMD).

The Windsor Framework; Packaging and Labelling Requirements – Aug 2023

The Windsor Framework; Packaging and Labelling Requirements – Aug 2023

by Steven Hewison | Aug 25, 2023 | Blog

From the 1st of January 2025 the supply of medicines to Northern Ireland will be governed by the Windsor Framework, which will replace the Northern Ireland Protocol.

Medicines, Ethics and Practice Edition 46 – July 2023

Medicines, Ethics and Practice Edition 46 – July 2023

by Steven Hewison | Jul 31, 2023 | Blog

The Royal Pharmaceutical Society have just released Medicines, Ethics and Practice Edition 46 – July 2023.

MHRA new recognition routes to access to new medicines

MHRA new recognition routes to access to new medicines

by Steven Hewison | Jun 5, 2023 | Blog, Brexit, MHRA

After Brexit the MHRA had been preparing to take over the role of sole approver of newly licensed medicines in the UK until now.

« Older Entries
Next Entries »

Recent Posts

  • FDA Warning Letters
  • Emerging issues – Communique from the GPhC
  • New MHRA/NICE Collaboration

Upcoming Courses

  • RP Forum – GxP Certificates for Customers and Supplier Qualification on 9 September 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 September 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 16 September 2025
  • GDP Audit Online Training on 1 October 2025 10:00 am
  • Licence Holder Training on 14 October 2025 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 11 to 15 August 2025
19 August 2025
Class 4 Medicines Defect Notification: Levetiracetam Accord 100mg/ml oral solution, Accord Healthcare Limited, UK, EL(25)A/40
14 August 2025
Field Safety Notices: 4 to 8 August 2025
12 August 2025
Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd, EL(25)A/39
7 August 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow